Effectiveness Treatment of a BRAF-ZKSCAN5 Fusion Gene Melanoma Case with Dabrafenib/Trametinib

The most important driver gene in malignant melanoma is the BRAF mutation, and molecularly targeted therapies targeting mutations, mainly V600E and V600k, are used in clinical practice. In this report, we treated a patient with malignant melanoma expressing a rare BRAF-ZKSCAN5 fusion gene with dabra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Hiroshi, Kano, Shinji, Yasui, Yukiko, Nojiri, Yuka, Yoshimitsu, Maki, Nakamura, Motoki, Morita, Akimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601785/
https://www.ncbi.nlm.nih.gov/pubmed/37900828
http://dx.doi.org/10.1159/000533822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601785/
https://www.ncbi.nlm.nih.gov/pubmed/37900828
http://dx.doi.org/10.1159/000533822

Ejemplares similares